Abstract
A method for obtaining direct dilatation of the coronary arteries by administering a therapeutically effective amount of a phospholamban inhibitor is described. Compounds which are effective in relieving the inhibitory effects of phospholamban on cardiac sarcoplasmic reticulum Ca2+ -ATPase are also described.
Original language | English |
---|---|
Patent number | US 6265421 |
IPC | 514-317 |
Priority date | 1997/06/25 |
Publication status | Published - 2001 Jul 24 |
Externally published | Yes |
Subject classification (UKÄ)
- Cardiology and Cardiovascular Disease
- Other Chemical Engineering
Free keywords
- phospholamban inhibitors
- Vasodilation : drug